Lifetime treatment with penicillamine, 1-1.5 g daily, is effective in chelating copper.
If treatment is started early, clinical and biochemical improvement can occur.
Urine copper levels should be monitored and the drug dose adjusted downwards after 2-3 years.
Serious side-effects of the drug occur in 10% and include skin rashes, leucopenia and renal damage.
Need to supplement pyridoxine
Trientine is the second line treatment for patients intolerant to penicillamine.
Oral Zinc is the third line. It compete eith copper for intestinal absorption.
Tetrathiomolybdate suitable for severe neurologic WD
Avoid chocolate, shellfish, liver, nuts, mushrooms.
All siblings and children of patients should be screened and treatment given even in the asymptomatic if there is evidence of copper accumulation.
|
A 50-year-old man is diagnosed with Wilson's disease. You are trying to make sense of his blood test results.
ReplyDeleteWhich one of the following would you expect to find in a patient with Wilson's disease?
(Please select 1 option)
1- Hypercalcaemia
2- Positive anti-mitochondrial antibody
3-Raised caeruloplasmin
4-Raised free serum copper Correct
5-Reduced urinary copper
Wilson's disease typically causes
reduced caeruloplasmin
raised urinary copper
raised free serum copper
Primary biliary cirrhosis typically causes a positive anti-mitochondrial antibody.
Anemia in patients with acute Wilson’s crisis is due to significant hemolysis. One other feature that is very suggestive of acute Wilson’s liver failure is alkaline phosphatase to bilirubin ratio < 2.0. It is not clear why the serum levels of alkaline phosphatase are drastically decreased in patients with acute liver failure due to Wilson’s disease. But alkaline phosphatase to bilirubin ratio < 2.0 in a patient with acute liver failure should always the raise of suspicion for Wilson’s disease.
ReplyDeleteSlit lamp examination oftentimes provides immediate diagnostic clues (by exhibiting KF rings) and should be obtained in every patient with acute liver failure with any suspicion of Wilson’s disease.
A 17-year-old otherwise healthy girl notes that her urine has become darker than usual and she is having a difficult time concentrating in school. Routine blood work is found to be significant for a hemoglobin level of 8 g/dL. Liver test results are significant for a total bilirubin of 9 mg/dL, alkaline phosphatase of 90 U/L, AST of 700 U/L, and ALT of 890 U/L. Hepatitis A/B/C serology results are negative. Which is the most likely diagnosis?
ReplyDelete1-Alcoholic hepatitis
2-Ischemic hepatitis
3-Wilson disease
4-Amanita phalloides poisoning
5-Autoimmune hepatitis (AIH)
This patient has Wilson’s disease. Wilson’s disease is most commonly diagnosed in children and young adults and should be suspected in this age group. This disorder results from a defect in the ATP7A gene and results in copper retention in the liver resulting in hepatocyte injury. Patients can present in various ways, from asymptomatic abnormalities in blood work to fulminant hepatic failure. Patients presenting with severe acute Wilson’s disease are often noted to have hemolysis with an elevated hyperbilirubinemia and anemia resulting in jaundice. AST and ALT levels are often quite elevated compared with the alkaline phosphatase, which is either normal or below normal in acute settings. Patients presenting in this manner need to be diagnosed expeditiously and transferred to a liver transplantation facility as copper chelators are not beneficial in this setting.
A 16-year-old high school student is brought to the emergency department by his mother because over the past two or three days he has become lethargic and confused. His family has noticed that over the past few months, he has become withdrawn and irritable and started to have problems with homework. Laboratory test results show that his hemoglobin level is 10.6 g/dL, total bilirubin is 26.4 mg/dL, direct bilirubin is 7.9 mg/dL, AST is 934 U/L, ALT is 788 U/L, alkaline phosphatase is 104 U/L, and INR is 1.7. Which of the following is the most appropriate course of treatment for this patient?
ReplyDelete1-Administer intravenous N-acetylcysteine.
2-Initiate a transplantation evaluation.
3-Initiate penicillamine therapy.
4-Infuse α1-antitrypsin.
5-Begin therapeutic phlebotomy.
This patient has Wilson’s disease and is presenting with fulminant hepatic failure with severe coagulopathy and encephalopathy. Acute intravascular hemolysis is usually present in this situation. Unlike fulminant viral hepatitis, Wilson’s disease is usually characterized by disproportionately low serum aminotransaminase levels, and the serum alkaline phosphatase level is in the normal or even low range. The serum bilirubin level is disproportionately elevated secondary to hemolysis. These patients do not respond well to chelation therapy and require urgent transplantation evaluation.